Gilead gets Sovaldi patent approval in India despite opposition
10-05-2016
MSF urges Indian Patent Office to reject Gilead Sovaldi patent
02-03-2016
pio3 / Shutterstock.com
Activist organisation Médecins Sans Frontières (MSF) has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Médecins Sans Frontières; Pfizer; Indian Patent Office; European Patent Office;
